Trial Profile
A Pilot Study of Dronabinol for Adult Patients With Primary Gliomas
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 17 Sep 2014
Price :
$35
*
At a glance
- Drugs Dronabinol (Primary)
- Indications Chemotherapy-induced nausea and vomiting
- Focus Adverse reactions
- 01 Apr 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov record.
- 21 Feb 2012 Planned end date changed from 1 Dec 2009 to 1 Jun 2013 as reported by ClinicalTrials.gov.
- 21 Feb 2012 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.